Open Access Green as soon as Postprint is submitted to ZB.
Unbiased identification of T-cell receptors Targeting immunodominant peptide-MHC complexes for T-cell receptor immunotherapy.
Hum. Gene Ther. 28, 1158-1168 (2017)
T-cell receptor (TCR) immunotherapy uses T cells engineered with new TCRs to enable detection and killing of cancer cells. Efficacy of TCR immunotherapy depends on targeting antigenic peptides that are efficiently presented by the best-suited major histocompatibility complex (MHC) molecules of cancer cells. However, efficient strategies are lacking to easily identify TCRs recognizing immunodominant peptide-MHC (pMHC) combinations utilizing any of the six possible MHC class I alleles of a cancer cell. We generated an MHC cell library and developed a platform approach to detect, isolate, and re-express TCRs specific for immunodominant pMHCs. The platform approach was applied to identify a human papillomavirus (HPV16) oncogene E5-specific TCR, recognizing a novel, naturally processed pMHC (HLA-B*15:01) and a cytomegalovirus-specific TCR targeting an immunodominant pMHC (HLA-B*07:02). The platform provides a useful tool to isolate in an unbiased manner TCRs specific for novel and immunodominant pMHC targets for use in TCR immunotherapy.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Immunotherapy ; T Cell Receptor (tcr) Discovery ; Tcr Gene Therapy ; Mhc Cell Library ; Immunodominance ; Human Papillamavirus Es; Antigen-presenting Cells; Gamma Elispot Assays; Tcr Gene-therapy; Dendritic Cells; Retroviral Vectors; Antitumor-activity; E5 Oncoprotein; Lymphocytes; Expression; Cancer
ISSN (print) / ISBN
1043-0342
e-ISSN
1557-7422
Quellenangaben
Volume: 28,
Issue: 12,
Pages: 1158-1168
Publisher
Mary Ann Liebert
Publishing Place
New Rochelle
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
AG Translationale Molekulare Immunologie (TMI)